Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Authors
Keywords
-
Journal
CLINICAL MICROBIOLOGY REVIEWS
Volume 36, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2023-04-17
DOI
10.1128/cmr.00059-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review
- (2023) Kelly A. Cairns et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination
- (2022) Yu-Chung Chuang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin
- (2022) Yu-Chung Chuang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- risk factors for persistent enterococcal bacteremia: a multicenter retrospective study.
- (2022) Linda Bussini et al. Journal of Global Antimicrobial Resistance
- Eosinophilic Syndromes Associated With Daptomycin Use: Re-exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia
- (2022) Katelyn A West et al. Open Forum Infectious Diseases
- Impact of infectious diseases consultation on the outcome of patients with enterococcal bacteremia: a systematic literature review and meta-analysis
- (2022) Joseph Tholany et al. Open Forum Infectious Diseases
- Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
- (2022) Bin Lin et al. Frontiers in Public Health
- Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection
- (2022) Yu-Chung Chuang et al. BIOMEDICINE & PHARMACOTHERAPY
- Short-course versus long-course antibiotic treatment for uncomplicated vancomycin-resistant enterococcal bacteraemia: a retrospective multicentre cohort study
- (2022) Christina Bahrs et al. CLINICAL MICROBIOLOGY AND INFECTION
- Ring-fused 2-pyridones effective against multidrug-resistant Gram-positive pathogens and synergistic with standard-of-care antibiotics
- (2022) Taylor M. Nye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity
- (2021) S. Luque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
- (2021) Laura Soldevila-Boixader et al. Antibiotics-Basel
- Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation
- (2021) Indy Sandaradura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Contezolid: First Approval
- (2021) Sheridan M. Hoy DRUGS
- Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series
- (2021) Alessandro Russo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimizing antimicrobial use: challenges, advances and opportunities
- (2021) Timothy M. Rawson et al. NATURE REVIEWS MICROBIOLOGY
- Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
- (2021) George Sakoulas et al. Open Forum Infectious Diseases
- Increasing Trend of Vancomycin-resistant Enterococci Bacteremia in a Tertiary Care Hospital of South India: A Three-year Prospective Study
- (2021) Anitha Gunalan et al. Indian Journal of Critical Care Medicine
- The COVID-19 pandemic: a threat to antimicrobial resistance containment
- (2021) Raspail C Founou et al. Future Science OA
- Combination Therapy of Chloramphenicol and Daptomycin for the Treatment of Infective Endocarditis Secondary to Multidrug Resistant Enterococcus faecium
- (2021) Sunish Shah et al. HOSPITAL PHARMACY
- Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)
- (2021) Cecilia G. Carvalhaes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020
- (2021) Simon Brinkwirth et al. Eurosurveillance
- Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
- (2021) Yuki Hanai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical impact of vancomycin‐resistant enterococci colonization in nonliver solid organ transplantation and its implications for infection control strategies: A single‐center, 10‐year retrospective study
- (2021) Alexandra C. McFarlane et al. Transplant Infectious Disease
- A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals
- (2021) Athena L.V. Hobbs et al. Journal of Global Antimicrobial Resistance
- 1243. Eravacycline in Bacteremia: A Case Series
- (2021) Justin A Andrade et al. Open Forum Infectious Diseases
- Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
- (2021) German A Contreras et al. Open Forum Infectious Diseases
- Real-Time Therapeutic Drug Monitoring (TDM)-Based Pharmacokinetic/Pharmacodynamic (PK/PD) Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case Study
- (2020) Pier Giorgio Cojutti et al. THERAPEUTIC DRUG MONITORING
- In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient
- (2020) Eric Wenzler et al. Open Forum Infectious Diseases
- Early Experience with Eravacycline for Complicated Infections
- (2020) S Alosaimy et al. Open Forum Infectious Diseases
- Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model
- (2020) Seyedehameneh Jahanbakhsh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Accumulation of Major Linezolid Metabolites in Patients with Renal Impairment
- (2020) Ernane Souza et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting
- (2020) Ouli Xie et al. BMC INFECTIOUS DISEASES
- How to design a study to evaluate therapeutic drug monitoring in infectious diseases?
- (2020) A.-G. Märtson et al. CLINICAL MICROBIOLOGY AND INFECTION
- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
- (2020) J. Turnidge et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
- (2020) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- One Health in hospitals: how understanding the dynamics of people, animals, and the hospital built-environment can be used to better inform interventions for antimicrobial-resistant gram-positive infections
- (2020) Kathryn R. Dalton et al. Antimicrobial Resistance and Infection Control
- Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients
- (2020) Laurens Manning et al. Open Forum Infectious Diseases
- Stopping the Routine use of Contact Precautions for Management of MRSA and VRE at Three Academic Medical Centers: An Interrupted Time Series Analysis
- (2020) Sarah Haessler et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus
- (2020) Jatinder Kaur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
- (2020) Takashi Ueda et al. BMC Pharmacology & Toxicology
- Impact of Inappropriate Antibiotic Therapy in Vancomycin-Resistant Enterococcus Bacteremia
- (2020) Waqas Aslam et al. AMERICAN JOURNAL OF THERAPEUTICS
- Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care–Associated Infections in Australia: A Retrospective Case-cohort Study
- (2020) X J Lee et al. CLINICAL INFECTIOUS DISEASES
- Streptogramins for the treatment of infections caused by Gram-positive pathogens
- (2020) Sophie Reissier et al. Expert Review of Anti-Infective Therapy
- Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations
- (2020) Federico Pea JOURNAL OF INFECTION AND CHEMOTHERAPY
- The Frequency of, and Factors Associated with Prolonged Hospitalization: A Multicentre Study in Victoria, Australia
- (2020) Richard Ofori-Asenso et al. Journal of Clinical Medicine
- Thirty years of VRE in Germany – “expect the unexpected”: The view from the National Reference Centre for Staphylococci and Enterococci
- (2020) Guido Werner et al. DRUG RESISTANCE UPDATES
- Resistance in Vancomycin-Resistant Enterococci
- (2020) William R. Miller et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex
- (2020) John Merlino et al. PATHOLOGY
- Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies
- (2020) Vanessa Grant-Di Felice et al. Surgical Infections
- Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases
- (2019) Sarah Weber et al. ANNALS OF HEMATOLOGY
- Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study
- (2019) Genovefa A Papanicolaou et al. CLINICAL INFECTIOUS DISEASES
- Utilizing genomic analyses to investigate the first outbreak of van A vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility
- (2019) Abby P. Douglas et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates
- (2019) Jonathan B. Mandell et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- The Enterococcus: a Model of Adaptability to Its Environment
- (2019) Mónica García-Solache et al. CLINICAL MICROBIOLOGY REVIEWS
- Reply to Cheng and Chuang
- (2019) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?
- (2019) George H Talbot et al. CLINICAL INFECTIOUS DISEASES
- Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections
- (2019) Lesley J. Scott DRUGS
- Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin
- (2019) Samira Dahesh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbiology and Preclinical Review of Omadacycline
- (2019) James A Karlowsky et al. CLINICAL INFECTIOUS DISEASES
- Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy
- (2019) Si-Ho Kim et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Prevalence of Infective Endocarditis in Enterococcus faecalis Bacteremia
- (2019) Anders Dahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genomics of vancomycin-resistant Enterococcus faecium
- (2019) Claire Gorrie et al. Microbial Genomics
- Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: findings from a monocentric, prospective, open-label, interventional study
- (2019) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Determining therapeutic trough ranges for linezolid
- (2019) Abdullah Alsultan SAUDI PHARMACEUTICAL JOURNAL
- Observational retrospective single‐centre study in Japan to assess the clinical significance of serum daptomycin levels in creatinine phosphokinase elevation
- (2019) Motozumi Ando et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice
- (2019) Gauri G Rao et al. THERAPEUTIC DRUG MONITORING
- Impact of Enterococcal Bacteremia in Liver Transplant Recipients
- (2019) Youn Jeong Kim et al. TRANSPLANTATION PROCEEDINGS
- Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis
- (2019) Changcheng Shi et al. Journal of Global Antimicrobial Resistance
- Impact on mortality of a bundle for the management of enterococcal bloodstream infection
- (2019) Michele Bartoletti et al. Open Forum Infectious Diseases
- The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections
- (2019) Mark Redell et al. Open Forum Infectious Diseases
- Economic evaluation of vancomycin-resistant enterococci (VRE) control practices: a systematic review
- (2019) C. MacDougall et al. JOURNAL OF HOSPITAL INFECTION
- Observational study to determine the optimal dose of daptomycin based on pharmacokinetic/pharmacodynamic analysis
- (2019) Tomoyuki Yamada et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
- (2018) Razieh Kebriaei et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests
- (2018) Shelley A. Campeau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy
- (2018) Ryan K Dare et al. CLINICAL INFECTIOUS DISEASES
- Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases
- (2018) J. Rello et al. CLINICAL MICROBIOLOGY AND INFECTION
- Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium
- (2018) Vidthiya Menon et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Combatting resistant enterococcal infections: a pharmacotherapy review
- (2018) Nicholas J Mercuro et al. EXPERT OPINION ON PHARMACOTHERAPY
- Daptomycin-induced Eosinophilic Pneumonia and a Review of the Published Literature
- (2018) Yoshitsugu Higashi et al. INTERNAL MEDICINE
- Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
- (2018) David B. Huang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review
- (2018) Farnaz Foolad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
- (2018) Yu-Chung Chuang et al. Scientific Reports
- Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
- (2018) Laura Puchter et al. Antimicrobial Resistance and Infection Control
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli
- (2018) Ryan L. Crass et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Current use of daptomycin and systematic therapeutic drug monitoring: clinical experience in a tertiary care institution
- (2018) Alicia Galar et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Omadacycline: A New Tetracycline Antibiotic
- (2018) John A. Dougherty et al. ANNALS OF PHARMACOTHERAPY
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Attributable mortality of hospital-acquired bloodstream infections in Ireland
- (2017) M. Brady et al. JOURNAL OF HOSPITAL INFECTION
- The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
- (2017) Jian Wang et al. Annals of Clinical Microbiology and Antimicrobials
- Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in anIn VitroPharmacokinetic-Pharmacodynamic Model
- (2016) Ashley D. Hall Snyder et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sending repeat cultures: is there a role in the management of bacteremic episodes? (SCRIBE study)
- (2016) J. Brad Wiggers et al. BMC INFECTIOUS DISEASES
- Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
- (2016) Bhavarth S. Shukla et al. CLINICAL INFECTIOUS DISEASES
- Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients
- (2016) Nicholas S. Britt et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
- (2016) Y.-C. Chuang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel
- (2016) Joe Pardo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
- (2016) George G. Zhanel et al. DRUGS
- Therapeutic drug management of linezolid: a missed opportunity for clinicians?
- (2016) Dario Cattaneo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis
- (2016) Ming Zhao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Oral pristinamycin for the treatment of resistant Gram-positive infections in patients with cancer: Evaluation of clinical outcomes
- (2016) J.C. Teng et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Variable linezolid exposure in ICU patients—possible role of drug-drug interactions
- (2016) Christoph Töpper et al. THERAPEUTIC DRUG MONITORING
- Characterization of Enterococcus faecium bacteriophage IME-EFm5 and its endolysin LysEFm5
- (2016) Pengjuan Gong et al. VIROLOGY
- Tedizolid for Treatment of Enterococcal Bacteremia
- (2016) Praveen Sudhindra et al. Open Forum Infectious Diseases
- Colonization with Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection among Patients with Malignancy: A Systematic Review and Meta-Analysis
- (2016) Michail Alevizakos et al. Open Forum Infectious Diseases
- β-Lactams Enhance Daptomycin Activity against Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium inIn VitroPharmacokinetic/Pharmacodynamic Models
- (2015) Jordan R. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?
- (2015) Federico Pea et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
- (2015) Larry M. Baddour et al. CIRCULATION
- Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic
- (2015) Steven D. Burdette et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
- (2015) Pamela A. Moise et al. CLINICAL THERAPEUTICS
- Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study
- (2015) Yoshio Takesue et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis
- (2015) Chatura Prematunge et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials
- (2015) N. Eliakim-Raz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- -Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
- (2015) J. R. Smith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy
- (2015) Moshe C. Ornstein et al. LEUKEMIA & LYMPHOMA
- Therapeutic Drug Monitoring of Daptomycin
- (2015) Claudine Reiber et al. THERAPEUTIC DRUG MONITORING
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2015) Taeksun Song et al. EBioMedicine
- Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
- (2015) Jennifer A. Johnson et al. Open Forum Infectious Diseases
- MRSA and VRE Colonization in Solid Organ Transplantation: A Meta-Analysis of Published Studies
- (2014) P. D. Ziakas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci
- (2014) Kayoko Hayakawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement
- (2014) D. Montange et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Daptomycin or Linezolid in Combination with Rifampin or Gentamicin against Biofilm-Forming Enterococcus faecalis or E. faecium in anIn VitroPharmacodynamic Model Using Simulated Endocardial Vegetations and anIn VivoSurvival Assay Using Galleria mellonella Larvae
- (2014) Megan K. Luther et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- Prosthetic Joint Infection
- (2014) A. J. Tande et al. CLINICAL MICROBIOLOGY REVIEWS
- Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight
- (2014) Takashi Niwa et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients
- (2014) H.-Y. Dong et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
- (2014) J.A. Roberts et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections
- (2013) Donald W. Whang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
- (2013) Chung-Chih Lai et al. BMC INFECTIOUS DISEASES
- Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization
- (2013) A.A.Y. Cheah et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Tigecycline: an update
- (2013) Gary E. Stein et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia
- (2013) F. Pea et al. INFECTION
- Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
- (2013) Antonello Di Paolo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genomic analysis of teicoplanin resistance emerging during treatment of vanB vancomycin-resistant Enterococcus faecium infections in solid organ transplant recipients including donor-derived cases
- (2013) Natasha E. Holmes et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
- (2013) R. Kullar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia
- (2013) Y. Nukui et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-Term Carriage of Vancomycin-Resistant Enterococci in Patients Discharged from Hospitals: a 12-Year Retrospective Cohort Study
- (2013) S. Karki et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Stewardship Approach for Optimizing Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Enterococcus Species
- (2013) A. Sango et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United States
- (2013) P. Brandon Bookstaver et al. PHARMACOTHERAPY
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis
- (2012) Carlo Tascini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin SynergyIn Vitrowith Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
- (2012) Jillian L. Descourouez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital
- (2012) Kyung Mok Sohn et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations
- (2012) B. T. Tsuji et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The rise of the Enterococcus: beyond vancomycin resistance
- (2012) Cesar A. Arias et al. NATURE REVIEWS MICROBIOLOGY
- Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature
- (2012) Bettina M. Knoll et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
- (2011) Federico Pea et al. ANNALS OF PHARMACOTHERAPY
- Therapeutic drug monitoring of antimicrobials
- (2011) Jason A. Roberts et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia
- (2011) T. Peel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms
- (2011) A. Holmberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital
- (2010) A. B. Reid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
- (2010) Sujata M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Quinupristin–dalfopristin versus linezolid for the treatment of vancomycin-resistant Enterococcus faecium bacteraemia: Efficacy and development of resistance
- (2010) Yong Pil Chong et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
- (2010) John B. Bossaer et al. SUPPORTIVE CARE IN CANCER
- Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin
- (2009) Amanda C Schutt et al. ANNALS OF PHARMACOTHERAPY
- Efficacy of Daptomycin in Implant-Associated Infection Due to Methicillin-Resistant Staphylococcus aureus: Importance of Combination with Rifampin
- (2009) A.-K. John et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Peptide Nucleic Acid Fluorescent In Situ Hybridization for Hospital-Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy
- (2008) G. N. Forrest et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence and management of drug-resistant enterococcal infections
- (2008) Cesar A Arias et al. Expert Review of Anti-Infective Therapy
- Renal function as a predictor of linezolid-induced thrombocytopenia
- (2008) Kazuaki Matsumoto et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline
- (2008) S. H. Zinner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pristinamycin as adjunctive therapy in the management of Gram-positive multi-drug resistant organism (MDRO) osteoarticular infection
- (2008) N. Ruparelia et al. JOURNAL OF INFECTION
- Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
- (2007) K. M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started